Main Article Content

Abstract

Antiphospholipid syndrome (APS) an autoimmune state of hypercoagulability caused by antiphospholipid antibodies. APS causes blood clots (thrombosis) in both arteries and veins, as well as pregnancy-related complications such as miscarriage, stillbirth, premature birth, and severe preeclampsia. [9,10]. Thrombosis is a pathophysiologic feature, but other factors such as complement activation may be important. Pregnant women with APS have an increased risk of recurrent miscarriage, intrauterine growth restriction, and premature birth. Placental infarction is often the cause of these complications.In addition, it can be the cause of preeclampsia, according to some authors, as it affects the bloodstream [1,5,6,8].

Keywords

antiphospholipid syndrome preeclampsia thrombosis F2 gene

Article Details

How to Cite
U., B. S. (2022). The Role of the F2 Gene in the Occurrence of Obstetric Complications in the form of Hypertensive Conditions During Pregnancy. Central Asian Journal of Medical and Natural Science, 3(2), 347-350. https://doi.org/10.17605/OSF.IO/3TMFD

References

  1. 1. Bazovaya M.YU. Optimizaciya dispansernogo nablyudeniya v rannie sroki gestacii zhenshchin s otyagoshchennym akusherskim anamnezom: Avtoref. dis.kand. med. nauk. Moskva. - 2013. - 12s.
  2. 2. Kornyushina E.A. Sovremennye podhody k terapii antifosfolipidnogo sindroma pri beremennosti (klinicheskij sluchaj) // ZHurnal akusherstva i zhenskih boleznej. - 2018. - T. 67. - №6. - C. 100-105. doi: 10.17816/JOWD676100-105.
  3. 3. Kerchelaeva S.B. Znachenie antitel k fosfolipidam i fosfolipid svyazyvayushchim belkam pri nerazvivayushchejsya beremennosti// Ros.vestnik akushera-ginekologa. 2003. - tom 3, № 4. - S.11 - 16.
  4. 4. Negmatshaeva, H. N. Kliniko-laboratorn oeobsled ovanievne beremennos tipacientok s antifosfolipidnymsindromom / H. N. // Medicinaizdravoohranenie : materialy V Mezhdunar. nauch. konf. (g. Kazan', maj 2017 g.). — Kazan' : Buk, 2017. — S. 63-65. —
  5. 5. Sidel'nikova V.M., Suhih G.T. Nevynashivanieberemennosti. - M.: MIA, 2010. [Sidel’nikova VM, Sukhikh GT. Nevynashivanieberemennosti. Moscow: MIA; 2010. (In Russ.)]
  6. 6. Tong M., Viall C. A., Chamley L. W. Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment (angl.) // Human Reproduction (angl.) russk. : journal. — 2014. — Vol. 21, no. 1. — P. 97—118. — doi:10.1093/humupd/dmu049. — PMID 25228006.
  7. 7. Ikhtiyarova, G.A., Dustova, N.K., Kudratova, R.R., Bakhramova, S.U., Khafizova, D.B. Pre-course training of women with reproductive loss of fetus in anamnesis (2021) Annals of the Romanian Society for Cell Biology, 25 (1), pp. 6219-6226.
  8. 8. Bakhramova, S.U., Ikhtiyarova, G.A., Dustova, N.K., Kudratova, R.R.
  9. 9. Thrombophilic complications in the development of gestional hypertension (Review) (2021) Annals of the Romanian Society for Cell Biology, 25 (1), pp. 6198-6205.
  10. 10. de Jong P.G., Goddijn M., Middeldorp S. Antithrombotic therapy for pregnancy loss (angl.) // Human Reproduction (angl.)russk.. — 2013. — Vol. 19, no. 6. — P. 656—673. — doi:10.1093/humupd/dmt019. — PMID 23766357.
  11. 11. Ruffatti A, Favaro M, Brucato A, et al. Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block. Transfus Apher Sci. 2015;53(3):269-278. doi: 10.1016/j.transci.2015.11.006.